Bibliographic record

Semaglutide in patients with heart failure with preserved ejection fraction and obesity

Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV, Shah…. New England Journal of Medicine 2023

Document identifier: CEI-BR-061
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, Hovingh GK, Kitzman DW, Lindegaard ML, Møller DV, Shah SJ, Treppendahl MB, Verma S, Abhayaratna W, Ahmed FZ, Chopra V, Ezekowitz J, Fu M, Ito H, Petrie MC
Title: Semaglutide in patients with heart failure with preserved ejection fraction and obesity
Source: New England Journal of Medicine
Year: 2023
Volume, issue, pages: 389(12):1069–1084
Digital object identifier: 10.1056/NEJMoa2306963
PubMed identifier: 37622681
Record type: Journal article
Institute identifier: CEI-BR-061

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Semaglutide	Compound monograph
Trial abstract: STEP-HFpEF	Trial abstract
Trial abstract: STEP-HFpEF-DM	Trial abstract
Synthesis: Incretin receptor agonists in heart failure with preserved ejection…	Evidence synthesis
4 citing documents.

§1.3Subject tags

semaglutide hfpef STEP-HFpEF

Compound Evidence Institute · CEI-BR-061 · https://compoundevidence.com/bibliography/kosiborod2023/ · retrieved 30 July 2026